These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Significant role of new oral cephem antibiotics. Focused on cefditoren pivoxil: discussion]. Shimada K Jpn J Antibiot; 1994 Aug; 47(8):951-66. PubMed ID: 7933539 [No Abstract] [Full Text] [Related]
8. Safety and efficacy of cefprozil as part of a parenteral-oral antibiotic regimen for the treatment of suppurative skeletal infections in children. Trujillo M; Ehrett S; Hoyt-Sehnert MJ; Shelton S; McCracken GH Clin Infect Dis; 1996 Oct; 23(4):843. PubMed ID: 8909865 [No Abstract] [Full Text] [Related]
9. The penicillins and cephalosporins. Choosing among the newer agents. Wagner KF; Counts GW Postgrad Med; 1978 Sep; 64(3):109-16. PubMed ID: 100772 [No Abstract] [Full Text] [Related]
10. [A clinical study on cefdinir 10% granule in pediatrics]. Satoh Y; Iwata S; Akita H; Sunakawa K Jpn J Antibiot; 1991 Oct; 44(10):1076-82. PubMed ID: 1762164 [TBL] [Abstract][Full Text] [Related]
11. [Laboratory and clinical studies of cefprozil in pediatric field]. Nishimura T; Tabuki K; Aoki S; Takagi M Jpn J Antibiot; 1992 Nov; 45(11):1582-91. PubMed ID: 1494239 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of cefdinir 10% granules in children]. Meguro H; Mori A; Fujii R; Terashima I Jpn J Antibiot; 1991 Oct; 44(10):1061-8. PubMed ID: 1762162 [TBL] [Abstract][Full Text] [Related]
13. Oral cephalosporins for use in a parenteral-to-oral switch programme. Rimmer DM Infection; 1995; 23 Suppl 2():S87-90. PubMed ID: 8537139 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of new oral antimicrobial agents and the experience with cefprozil--a broad-spectrum oral cephalosporin. Klein JO Clin Infect Dis; 1992 Jun; 14 Suppl 2():S183. PubMed ID: 1617035 [No Abstract] [Full Text] [Related]
16. [Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients]. Arai S; Sono R; Ito M; Sakurai M; Ihara T; Kamiya H; Shimizu S; Nishi H; Inoue M; Kojima M Jpn J Antibiot; 1992 Nov; 45(11):1571-81. PubMed ID: 1494238 [TBL] [Abstract][Full Text] [Related]
17. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs. Neu HC Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316 [TBL] [Abstract][Full Text] [Related]
18. [Laboratory and clinical studies on cefprozil granules in pediatrics]. Akita H; Sato Y; Iwata S; Sunakawa K Jpn J Antibiot; 1992 Nov; 45(11):1526-36. PubMed ID: 1494235 [TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on 10% cefdinir granules in pediatric infections]. Niinou K; Nakazawa S; Sato H Jpn J Antibiot; 1991 Oct; 44(10):1069-75. PubMed ID: 1762163 [TBL] [Abstract][Full Text] [Related]